Biblio

Export 326 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is I  [Clear All Filters]
Journal Article
V. Bonet-Costa, Herranz-Pérez, V., Blanco-Gandía, M. C., Mas-Bargues, C., Inglés, M., Garcia-Tarraga, P., Rodriguez-Arias, M., Miñarro, J., Borras, C., Garcia-Verdugo, J. Manuel, and Viña, J., “Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 3, pp. 701-11, 2016.
M. Isserles, Daskalakis, Z. J., Kumar, S., Rajji, T. K., and Blumberger, D. M., “Clinical Effectiveness and Tolerability of Electroconvulsive Therapy in Patients with Neuropsychiatric Symptoms of Dementia.”, J Alzheimers Dis, vol. 57, no. 1, pp. 45-51, 2017.
L. Tariciotti, Casadei, M., Honig, L. S., Teich, A. F., Ii, G. M. McKhann, Tosto, G., and Mayeux, R., “Clinical Experience with Cerebrospinal Fluid Aβ42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1417-1425, 2018.
E. Morenas-Rodriguez, Sala, I., Subirana, A., Pascual-Goñi, E., Sánchez-Saudinós, M. Belén, Alcolea, D., Illán-Gala, I., Carmona-Iragui, M., Ribosa-Nogué, R., Camacho, V., Blesa, R., Fortea, J., and Lleo, A., “Clinical Subtypes of Dementia with Lewy Bodies Based on the Initial Clinical Presentation.”, J Alzheimers Dis, vol. 64, no. 2, pp. 505-513, 2018.
R. Thangavel, Bhagavan, S. M., Ramaswamy, S. Beladakere, Surpur, S., Govindarajan, R., Kempuraj, D., Zaheer, S., Raikwar, S., Ahmed, M. E., Selvakumar, G. Pushpavath, Iyer, S. S., and Zaheer, A., “Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 61, no. 2, pp. 553-560, 2018.
J. M. Walker, Gonzales, M. M., Goette, W., Farrell, K., Iii, C. L. White, Crary, J. F., and Richardson, T. E., “Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies.”, J Alzheimers Dis, vol. 92, no. 3, pp. 1037-1049, 2023.
A. Espinosa, Alegret, M., Pesini, P., Valero, S., Lafuente, A., Buendia, M., San José, I., Ibarria, M., Tejero, M. A., Giménez, J., Ruiz, S., Hernandez, I., Pujadas, F., Martínez-Lage, P., Munuera, J., Arbizu, J., Tárraga, L., Hendrix, S. B., Ruiz, A., Becker, J. T., Landau, S. M., Sotolongo-Grau, O., Sarasa, M., and Boada, M., “Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.”, J Alzheimers Dis, vol. 57, no. 2, pp. 447-459, 2017.
S. Yumoto, Kakimi, S., and Ishikawa, A., “Colocalization of Aluminum and Iron in Nuclei of Nerve Cells in Brains of Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1267-1281, 2018.
M. Ejaz Ahmed, Iyer, S., Thangavel, R., Kempuraj, D., Selvakumar, G. Pushpavath, Raikwar, S. P., Zaheer, S., and Zaheer, A., “Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1143-1160, 2017.
T. Kishi, Matsuda, Y., and Iwata, N., “Combination Therapy of Serotonin Reuptake Inhibitors and Memantine for Obsessive- Compulsive Disorder: A Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials.”, J Alzheimers Dis, vol. 64, no. 1, pp. 43-48, 2018.
S. Matsunaga, Kishi, T., and Iwata, N., “Combination Therapy with Zonisamide and Antiparkinson Drugs for Parkinson's Disease: A Meta-Analysis.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1229-1239, 2017.
A. Dodich, Cerami, C., Cappa, S. F., Marcone, A., Golzi, V., Zamboni, M., Giusti, M. Cristina, and Iannaccone, S., “Combined Socio-Behavioral Evaluation Improves the Differential Diagnosis Between the Behavioral Variant of Frontotemporal Dementia and Alzheimer's Disease: In Search of Neuropsychological Markers.”, J Alzheimers Dis, vol. 61, no. 2, pp. 761-772, 2018.
A. Niwa, Ii, Y., Shindo, A., Matsuo, K., Ishikawa, H., Taniguchi, A., Takase, S., Maeda, M., Sakuma, H., Akatsu, H., Hashizume, Y., and Tomimoto, H., “Comparative Analysis of Cortical Microinfarcts and Microbleeds using 3.0-Tesla Postmortem Magnetic Resonance Images and Histopathology.”, J Alzheimers Dis, vol. 59, no. 3, pp. 951-959, 2017.
A. Niwa, Ii, Y., Shindo, A., Matsuo, K., Ishikawa, H., Taniguchi, A., Takase, S., Maeda, M., Sakuma, H., Akatsu, H., Hashizume, Y., and Tomimoto, H., “Comparative Analysis of Cortical Microinfarcts and Microbleeds using 3.0-Tesla Postmortem Magnetic Resonance Images and Histopathology.”, J Alzheimers Dis, vol. 59, no. 3, pp. 951-959, 2017.
A. Medoro, Bartollino, S., Mignogna, D., Passarella, D., Porcile, C., Pagano, A., Florio, T., Nizzari, M., Guerra, G., Di Marco, R., Intrieri, M., Raimo, G., and Russo, C., “Complexity and Selectivity of γ-Secretase Cleavage on Multiple Substrates: Consequences in Alzheimer's Disease and Cancer.”, J Alzheimers Dis, vol. 61, no. 1, pp. 1-15, 2018.
K. Nho, Ramanan, V. K., Horgusluoglu, E., Kim, S., Inlow, M. H., Risacher, S. L., McDonald, B. C., Farlow, M. R., Foroud, T. M., Gao, S., Callahan, C. M., Hendrie, H. C., Niculescu, A. B., and Saykin, A. J., “Comprehensive Gene- and Pathway-Based Analysis of Depressive Symptoms in Older Adults.”, J Alzheimers Dis, 2015.
F. Oluwasegun Ishabiyi, Ogidi, J. Okwudirich, Olukade, B. Adejoke, Amorha, C. Christabel, El-Sharkawy, L. Y., Okolo, C. Calistus, Adeniyi, T. Mary, Atasie, N. Hope, Ibrahim, A., and Balogun, T. Adewale, “Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S67-S85, 2023.
F. Oluwasegun Ishabiyi, Ogidi, J. Okwudirich, Olukade, B. Adejoke, Amorha, C. Christabel, El-Sharkawy, L. Y., Okolo, C. Calistus, Adeniyi, T. Mary, Atasie, N. Hope, Ibrahim, A., and Balogun, T. Adewale, “Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S67-S85, 2023.
A. Subotic, McCreary, C. R., Saad, F., Nguyen, A., Alvarez-Veronesi, A., Zwiers, A. M., Charlton, A., Beaudin, A. E., Ismail, Z., G Pike, B., and Smith, E. E., “Cortical Thickness and Its Association with Clinical Cognitive and Neuroimaging Markers in Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1663-1671, 2021.
M. Nakanishi, Igarashi, A., Ueda, K., Brnabic, A. J. M., Treuer, T., Sato, M., Kahle-Wrobleski, K., Meguro, K., Yamada, M., Mimura, M., and Arai, H., “Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study.”, J Alzheimers Dis, vol. 74, no. 1, pp. 127-138, 2020.
N. Baazaoui and Iqbal, K., “COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences.”, J Alzheimers Dis, vol. 88, no. 2, pp. 399-416, 2022.
N. Saji, Ishihara, Y., Murotani, K., Uchiyama, A., Takeda, A., Sakurai, T., and Matsushita, K., “Cross-Sectional Analysis of Periodontal Disease and Cognitive Impairment Conducted in a Memory Clinic: The Pearl Study.”, J Alzheimers Dis, vol. 96, no. 1, pp. 369-380, 2023.
L. Iaccarino, Chiotis, K., Alongi, P., Almkvist, O., Wall, A., Cerami, C., Bettinardi, V., Gianolli, L., Nordberg, A., and Perani, D., “A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.”, J Alzheimers Dis, vol. 59, no. 2, pp. 603-614, 2017.
A. Di Carlo, Baldereschi, M., Lamassa, M., Bovis, F., Inzitari, M., Solfrizzi, V., Panza, F., Galluzzo, L., Scafato, E., and Inzitari, D., “Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study.”, J Alzheimers Dis, vol. 53, no. 2, pp. 505-15, 2016.
A. Di Carlo, Baldereschi, M., Lamassa, M., Bovis, F., Inzitari, M., Solfrizzi, V., Panza, F., Galluzzo, L., Scafato, E., and Inzitari, D., “Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study.”, J Alzheimers Dis, vol. 53, no. 2, pp. 505-15, 2016.

Pages